Objective To test the hypothesis that feeding and antibiotic exposures affect intestinal barrier maturation in preterm infants, we serially measured intestinal permeability (IP) biomarkers in infants <33 weeks gestation (gestational age [GA]) during the first 2 weeks of life.
Results In a cohort of 43 subjects, the lactulose/rhamnose ratio was increased on day 1 and decreased over 2 weeks, but remained higher in infants born at ≤28 weeks of gestation compared with IP in infants born at >28 weeks of gestation. Exclusive breastmilk feeding was associated with more rapid maturation in intestinal barrier function. A cluster analysis of 35 subjects who had urine samples from all time points revealed 3 IP patterns (cluster 1, normal maturation: n = 20 [57%]); cluster 2, decreased IP during the first week and subsequent substantial increase: n = 5 [14%]); and cluster 3, delayed maturation: n = 10 [29%]). There were trends toward more prolonged antibiotic exposure (P = .092) and delayed initiation of feeding ≥4 days (P = .064) in infants with abnormal IP patterns.
Conclusions Intestinal barrier maturation in preterm infants is GA and postnatal age dependent, and is influ- Trial registration ClinicalTrials.gov: NCT01756040. N ecrotizing enterocolitis (NEC), a life-threatening, gastrointestinal emergency affects approximately 7%-10% of very low birthweight preterm neonates 1, 2 with mortality as high as 30%-50%. 3 Although breast milk has been shown to be protective against NEC, 4, 5 postnatal antibiotic exposure may increase the risk for NEC. 6, 7 Intestinal barrier immaturity is the proximate cause of susceptibility to NEC in preterm neonates, 8, 9 but few preterm infants born at <30 weeks of gestation have been included in prior studies of intestinal permeability (IP) [10] [11] [12] [13] [14] [15] and the impact of current feeding practices and antibiotic exposures on intestinal barrier maturation in the extremely preterm population is unknown.
The percent urinary excretion of orally administered isotonic solutions of the nonmetabolized sugars lactulose and rhamnose as markers of the intestinal paracellular and transcellular pathways, respectively, is the gold standard to assess IP. These tests have been used extensively for >30 years to assess IP in adults [16] [17] [18] and in preterm [10] [11] [12] [13] [14] [15] and term infants, 13, 19, 20 as well as in older children. The sugar probes have been used safely to assess IP in newborns with birth asphyxia, 10 NEC, 11 and congenital heart disease. 20, 21 Other markers of impaired intestinal barrier function include zonulin in adults 22 and alpha-1-anti-trypsin (A1AT) in children. 23 Zonulin is a 47-kDA eukaryotic cellular protein that regulates the intestinal epithelial paracellular pathway by reversibly opening mature tight junctions 24 and is up-regulated in several autoimmune diseases, including celiac disease and type 1 diabetes. 22 Whether zonulin is involved in tight junction maturation in preterm infants is unknown. Determination of fecal A1AT is used routinely in clinical practice as an indicator of substantial increased IP and protein-losing enteropathy. 23 To test the hypothesis that feeding and antibiotic exposures modulate intestinal barrier function in preterm infants, we conducted a prospective study to measure -32 6/7 weeks gestation <4 days of age were screened for study eligibility and parental consent of eligible subjects was obtained (ClinicalTrials.gov: NCT01756040). The institutional review boards of both institutions approved the study. Exclusion criteria included nonviability or planned withdrawal of life support; triplet or higher order multiples; severe asphyxia (Apgar score < 3 at 5 minutes and cord pH < 7.0); lethal chromosomal abnormalities; cyanotic congenital heart disease; intestinal atresia or perforation; abdominal wall defects; significant gastrointestinal dysfunction (eg, heme-positive stools, abdominal distension (girth > 2 cm baseline) or bilious emesis/ aspirates, and infants with galactosemia or other forms of galactose intolerance. Before study procedures, a complete physical examination including vital signs, weight, height, and head circumference was performed. Demographic, clinical, and adverse events data were collected from the medical record.
Both participating clinical centers used the same standardized feeding protocol. Feeds were initiated between the first and fourth days of life depending on clinical stability. After initial feeds of 10 mL/kg expressed breast milk or 20 kcal/oz preterm formula daily for 3-5 days, feedings were advanced by 20 mL/ kg/d until 100 mL/kg/d was reached. Subsequently, caloric density was advanced to 24 kcal/oz before increasing feeding volume by 20 mL/kg/d to 150 mL/kg/d. Feedings were held or discontinued for signs of feeding intolerance, such as abdominal distension, gastric residuals, or hematochezia, or for clinical deterioration.
Lactulose/Rhamnose Sugar Absorption Test and Sample Collection
On each of the 3 study days (days 1, 8 ± 2, and 15 ± 2), participants received 1 mL/kg La/Rh solution (8.6 g of lactulose [Cumberland Pharmaceuticals, Nashville, TN] + 140 mg of rhamnose [Saccharides, Inc, Calgary, Alberta, Canada]/ 100 mL) by nipple or by gavage via a clinically indicated orogastric tube. 12 A minimum of 2 mL of urine was collected over a 4-hour period after the La/Rh dose was administered, with cotton balls placed in the infants' diaper. The total urine volume recorded included the volume extracted from the cotton balls in addition to the estimated volume of urine that leaked into the diaper determined by the diaper weight. The test was repeated the next day if <2 mL urine was collected. If there were signs of feeding intolerance (increased abdominal girth > 2 cm, heme-positive stools, or gastric residuals), the sugar solution administration was either delayed until resolution of symptoms within the study four day window for each timepoint or not done. Serum (total 0.5 mL) was collected by heel stick 90-120 minutes after La/Rh dosing to measure La/Rh 25 and serum zonulin. A stool sample (~1 g) was collected within 8 hours of the sugar probe dosing for A1AT analysis. Urine, serum, and stool samples were stored at −80°C until analysis. The amount of lactulose and rhamnose in each sample was measured using high-performance liquid chromatography and adjusted for urine volume. 26 The fractional urinary excretion of lactulose and rhamnose was calculated as the ratio of the total urinary excretion of each sugar probe to the total oral dose of the probe. For each subject, the lactulose/rhamnose ratio (La/Rh ratio) was calculated as the fractional excretion of lactulose divided by that of rhamnose. 27 A La/Rh ratio of >0.05 was considered indicative of increased IP.
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Serum Zonulin Western Blot Serum samples (70 mg per well) were run under nondenaturing conditions on 4%-20% Tris-Glycine gels (Invitrogen, Waltham, Massachusetts). Protein was transferred onto a PVDF membrane (Millipore, Billerica, Massachusetts) and probed with 1.5 mg/mL mouse monoclonal zonulin antibody (Bio-Rad, Hercules, California). Bands were detected with Alexa Flor 680 conjugated goat anti-mouse IgG antibodies (ThermoFisher, Waltham, Massachusetts). Bands were visualized and densitometry was measured using Image Studio software (LI-COR Biosciences, Lincoln, Nebraska). All samples were normalized to a healthy term control reference sample run separately on each gel.
Stool A1AT ELISA
Stool samples diluted 1:250 according to the manufacturer's protocol were analyzed by double sandwich LISA (Eagle Biosciences, Nashua, New Hampshire) and results expressed as micrograms per gram of stool.
Statistical Analysis
The La/Rh ratio, serum zonulin, and stool A1AT data are represented as the mean and SD at each of the 3 time points. Categorical data were compared using the c 2 test and continuous data were compared with the Student t test. To quantify the association between urine La/Rh ratio, serum zonulin, and stool A1AT, Pearson correlation coefficients between the gold standard urinary La/Rh ratio and each of the other IP measures were calculated. IP patterns were differentiated using cluster analysis based on Ward minimum variance method, as implemented in SAS 9.3 (SAS Institute, Cary, North Carolina).
Results
Forty-four subjects were enrolled over an 18-month period from April 15, 2013, to October 15, 2014, and 43 subjects received ≥1 dose of sugar solution (Figure 1 ; available at www.jpeds.com) (ClinicalTrials.gov: NCT01756040). Demographic characteristics of the participants are represented in the Table. Because we were interested in the maturation of THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 183 intestinal barrier function in the extremely low GA infants, we analyzed the data for the entire cohort and stratified by GA ≤ 28 weeks (n = 12) and GA > 28 weeks (n = 31). The GA strata were similar in sex and race composition and obstetrical factors. However, feeding was delayed and antibiotic exposure more common and for longer durations in the less mature infants (GA ≤ 28 weeks). There was a trend toward higher exclusive breast milk feedings in the less mature infants. No subject developed NEC during their neonatal intensive care unit stay.
As shown in Figure 2 , A, on average, IP was increased on study day 1, decreased over 2 weeks, but remained higher in infants born at ≤28 weeks of gestation compared with IP in infants born at >28 weeks of gestation (P = .015, study day 8).
Only one-third of infants ≤28 weeks of gestation developed normal intestinal barrier function (La/Rh < 0.05) by study day 15 (Figure 2, B) . A cluster analysis of 35 subjects who had urine samples successfully collected at all 3 time points revealed that there were 3 distinct patterns of IP during the first 2 weeks of life (cluster 1, normal maturation: n = 20 [57%]); cluster 2, decrease IP during the first week and subsequent substantial increase: n = 5 [14%]); and cluster 3, delayed maturation: n = 10
[29%]) (Figure 2, C) . Further analysis of factors associated with abnormal IP patterns (clusters 2 and 3) revealed trends toward a more prolonged duration of antibiotic exposure (≥4 days) (10/15 [67%] vs 7 [35%]; P = .092) and delayed initiation of feeding (≥4 days) (5 [33%] vs 1 [5%]; P = .064) in infants with abnormal maturation patterns compared with infants with normal maturation. However, it is difficult to tease out which may be the important factor. There was a trend towards greater co-exposure to prolonged antibiotics and delayed feeding of ≥4 days in infants with abnormal maturation patterns than in infants with normal maturation (4/15 [27%] vs 1/20 [5%]; P = .141). Compared with infants fed preterm formula with or without expressed breast milk (n = 18), infants fed exclusively with expressed breast milk (n = 25) demonstrated more rapid improvement in intestinal barrier function on study day 15 (P = .0088) (Figure 2, D) .
Gestational and postnatal age-dependent changes in serum zonulin relative to a healthy full-term control infant are represented in Figure 3 , A. Although serum zonulin levels were low relative to a healthy full-term control, levels were significantly higher in infants born at >28 weeks of gestation compared with infants born at ≤28 weeks of gestation on day 1 (P = .012). Serum zonulin did not correlate with urinary La/ Rh ratios (Figure 3, B) . Although there was considerable variability in stool A1AT concentrations on study day 1, stool A1AT decreased over time similar to urinary La/Rh, indicating maturation of the intestinal barrier (Figure 3, C) . Although serum lactulose/rhamnose has been measured in serum of infants >4 months of age, 25 rhamnose was undetectable in serum samples from our cohort collected 90-120 minutes after sugar solution dosing, so the La/Rh ratio could not be calculated (data not shown).
Discussion
Our data suggest that intestinal barrier function is impaired in preterm infants and maturation depends on gestational and postnatal age, and may be altered by feeding and antibiotic exposures, with a maturational effect of breast milk feeding. Although intestinal barrier function improved over time in 57% of subjects, IP increased during the second week or maturation was delayed in the remaining infants. Almost one-half of all study subjects and >90% of subjects born at ≤28 weeks of gestation were treated with antibiotics for >4 days, a known risk factor for NEC and death, 6, 28 suggesting this is a modifiable risk factor. Study limitations included the small sample size, an inability to distinguish the effects of delayed initiation of feeding and prolonged antibiotics because antibiotic use and delayed feeding commonly occurred together, and the challenges of adequate urine collection for the dual sugar permeability testing.
As confirmed in the current study, epithelial barrier integrity is itself dynamic and matures over time, starting soon after birth, although the mechanisms regulating dynamic permeability are poorly understood. Although IP is higher at birth in preterm than term infants, previous studies observed that POL, preterm onset of labor; PPROM, preterm premature rupture of membranes; ROM, rupture of membranes. *Data are expressed as n (%) or mean ± SD.
usually there is rapid maturation of the intestinal barrier over the first few days of life in both populations, 29 suggesting that postnatal introduction of feeding accelerates maturation in both term and preterm infants. Whether IP is related to GA among preterm infants has remained controversial. In agreement with the current study, Rouwet et al 12 observed that IP was higher at 1 week of age in infants born at <28 weeks of gestation compared with more mature infants. However, in contrast with our study, all infants in the previous study received exclusive parenteral nutrition for the first week of life. In our study, feeding was were initiated before 4 days of age in 86% of the subjects. Other studies did not find an association of GA with IP in preterm infants born at <34 weeks of gestation in the first few weeks of life, but feeding practices were not noted in several studies 10, 29 and may have differed significantly from current practice. Despite similar cohort characteristics and feeding protocol with the current study, the study by Taylor et al 30 did not find an association of GA with IP measured by urinary lactulose/mannitol ratio. However, they did not evaluate IP at <7 days of age and did not report antibiotic exposures.
There is accumulating evidence that timing of the initiation of feeds, feeding advancement, and feeding type impact IP during the vulnerable first few weeks of life. Aberrant patterns of late increase in IP and delayed maturation were associated with delayed initiation of feeding. Exclusive breast milk feeding was associated with more rapid improvement in intestinal barrier function, consistent with prior studies in term 31 and preterm infants. 14, 30, 32 Multiple retrospective and prospective, randomized trials have demonstrated the beneficial effect of breast milk feeding on reducing the risk for NEC in preterm infants. [33] [34] [35] [36] [37] [38] In a secondary analysis of the National Institute of Child Health and Human Development glutamine trial, Colaizy et al 5 reported a 12-fold increased risk of NEC associated with exclusive formula feeding compared with exclusive breast milk feeding in preterm neonates.
Although the mechanism(s) by which breast milk improves the intestinal barrier is not known, it is likely to involve breast milk components such as the oligosaccharides that influence the intestinal microbiota, and other immunomodulatory factors such as lactoferrin and human milk peptides. 39 However, supplementing breast milk or preterm formula with a prebiotic mixture of nonhuman milk neutral oligosaccharides did not improve intestinal barrier function compared with placebo in a randomized trial of infants born at <32 weeks of gestation, but supplementing preterm formula with the probiotic strain Bifidobacterium lactis improved barrier function at study day 30. 40 Future studies of interventions to prevent NEC should include measures of IP to identify high-risk infants and the impact of the intervention on intestinal barrier function.
Because adequate urine collection in preterm infants is challenging and analysis of the sugar probes by high-performance liquid chromatography is time consuming, we evaluated alternative biomarkers for intestinal barrier function in this study. Because it was demonstrated previously that zonulin is involved in intestinal epithelial paracellular pathway regulation, 41, 42 intestinal innate immunity and is up-regulated in several autoimmune diseases, 22 we evaluated whether serum zonulin would be a relatively easy to measure biomarker to monitor IP maturation in preterm infants and identify those at risk for NEC. However, serum zonulin measured by immunoblotting did not correlate with the urinary La/Rh ratios in this study, suggesting that zonulin is not involved in tight junction maturation. Although fecal A1AT is used routinely as a biomarker of severe protein-losing enteropathy in older children, there was considerable variability in stool A1AT concentrations in stool samples from preterm infants in the current study. Our analysis of multiple measures of IP indicates that the administration of the nonmetabolized sugar probes lactulose and rhamnose as markers of transcellular and paracellular pathways, respectively, remains the gold standard for assessment of IP in newborns. ■ October 15, 2014) . One infant died from acute pulmonary hemorrhage after consent was obtained, but before the study solution was administered. At least 1 dose of study solution was administered to 43 subjects. LAR, Legally Authorized Representative.
